Join to view full profile
1010 Edgehill Rd NCharlotte, NC 28207
Phone+1 704-446-1900
Fax+1 704-466-6084
Dr. Brooks is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Neurology, 1976 - 1978
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1972 - 1974
Boston University Medical CenterResidency, Internal Medicine, 1970 - 1972
Harvard Medical SchoolClass of 1969
Certifications & Licensure
WI State Medical License 1982 - 2027
NC State Medical License 2008 - 2026
MD State Medical License 1976 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2020
- CMS Meaningful Use Stage 2 Certification HealthSentry, Cerner Corporation, 2013, 2017
- CMS Meaningful Use Stage 2 Certification P2 Sentinel, Cerner Corporation, 2013, 2017
Clinical Trials
Publications & Presentations
PubMed
- 7 citationsEfficacy of Radicava® IV (intravenous edaravone) in subjects with differing trajectories of disease progression in amyotrophic lateral sclerosis: Use of a novel statis...Erik P Pioro, Benjamin Rix Brooks, Ying Liu, Jeffrey Zhang, Stephen Apple
Journal of the Neurological Sciences. 2024-12-15 - 9 citationsThe effects of intervention with intravenous edaravone in Study 19 on hospitalization, tracheostomy, ventilation, and death in patients with amyotrophic lateral sclero...Benjamin Rix Brooks, Erik P Pioro, Takeshi Sakata, Fumihiro Takahashi, Melissa Hagan
Muscle & Nerve. 2023-10-01 - 5 citationsAmyotrophic Lateral Sclerosis Quality Measurement Set 2022 Update: Quality Improvement in Neurology.Kathryn A Kvam, Michael Benatar, Alisa Brownlee, Tracie Caller, Rohit R Das
Neurology. 2023-08-01
Press Mentions
Mitsubishi Tanabe Pharma America Announces Real-World Data Analysis of Survival with RADICAVA® (Edaravone)August 15th, 2022- Mitsubishi Tanabe Pharma America Announces Long-Term Findings from Post-Marketing Safety Study of RADICAVA® (Edaravone)June 29th, 2022
- #AAN2022 – US Real-World Data Show Radicava Boosts Survival RateApril 5th, 2022
Grant Support
- Tamoxifen Therapy On Mean Percent Predicted Isometric Strength In ALSNational Center For Research Resources2005
- Phase II Study Of Hu23f2g In Acute Excerbations Of Multiple SclerosisNational Center For Research Resources1998–2002
- Phase I Trial Of R-Methubdnf Given By Daily Injection To Patients With ALSNational Center For Research Resources1996
- Phase I Safety And Tolerability Study Of BDNF In Patients With ALSNational Center For Research Resources1995–1996
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: